Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lidia Sabater

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Brain : a Journal of Neurology|January 16, 2026
Brainstem pathology in anti-IgLON5 disease: new insights into early events and tau progressionRaphael Reinecke, Sophie Nitsch, Francisca Faber, et al.
JAMA Neurology|August 4, 2025
Early Treatment With Intravenous Immunoglobulins and Outcomes of Patients With Anti-IgLON5 DiseaseThomas Grüter, Carles Gaig, Yvette S Crijnen, et al.
Frontiers in Immunology|June 3, 2024
HLA dependency and possible clinical relevance of intrathecally synthesized anti-IgLON5 IgG4 in anti-IgLON5 diseaseInga Koneczny, Stefan Macher, Markus Hutterer, et al.
Brain : a Journal of Neurology|July 25, 2022
Distinct movement disorders in contactin-associated-protein-like-2 antibody-associated autoimmune encephalitisFelix Gövert, Ligia Abrante, Jos Becktepe, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 7, 2023
mRNA COVID-19 Vaccination Does Not Exacerbate Symptoms or Trigger Neural Antibody Responses in Multiple SclerosisYolanda Blanco, Domingo Escudero, Cinta Lleixà, et al.
Annals of Neurology|April 13, 2026
Relapses, Comorbidities, and Predictors of Outcome in Anti-GABA<sub>A</sub> Receptor EncephalitisClaudia Papi, Chiara Milano, Laura Marmolejo, et al.
Brain : a Journal of Neurology|July 12, 2025
Brain atrophy patterns in anti-IgLON5 diseaseSelina M Yogeshwar, Frederik Bartels, Thomas Grüter, et al.
Brain : a Journal of Neurology|March 1, 2024
HLA-DQB1*05 subtypes and not DRB1*10:01 mediates risk in anti-IgLON5 diseaseSelina M Yogeshwar, Sergio Muñiz-Castrillo, Lidia Sabater, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 13, 2026
Muscle Regeneration Failure May Lead to Clinical Features of Myopathy in Anti-IgLON5 DiseaseYvette S Crijnen, Verena Endmayr, Suzanne C Franken, et al.
Acta Neuropathologica|October 14, 2024
Neuropathological spectrum of anti-IgLON5 disease and stages of brainstem tau pathology: updated neuropathological research criteria of the disease-related tauopathyEllen Gelpi, Raphael Reinecke, Carles Gaig, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Brain : a Journal of Neurology|January 16, 2026
Brainstem pathology in anti-IgLON5 disease: new insights into early events and tau progressionRaphael Reinecke, Sophie Nitsch, Francisca Faber, et al.
JAMA Neurology|August 4, 2025
Early Treatment With Intravenous Immunoglobulins and Outcomes of Patients With Anti-IgLON5 DiseaseThomas Grüter, Carles Gaig, Yvette S Crijnen, et al.
Frontiers in Immunology|June 3, 2024
HLA dependency and possible clinical relevance of intrathecally synthesized anti-IgLON5 IgG4 in anti-IgLON5 diseaseInga Koneczny, Stefan Macher, Markus Hutterer, et al.
Brain : a Journal of Neurology|July 25, 2022
Distinct movement disorders in contactin-associated-protein-like-2 antibody-associated autoimmune encephalitisFelix Gövert, Ligia Abrante, Jos Becktepe, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 7, 2023
mRNA COVID-19 Vaccination Does Not Exacerbate Symptoms or Trigger Neural Antibody Responses in Multiple SclerosisYolanda Blanco, Domingo Escudero, Cinta Lleixà, et al.
Annals of Neurology|April 13, 2026
Relapses, Comorbidities, and Predictors of Outcome in Anti-GABA<sub>A</sub> Receptor EncephalitisClaudia Papi, Chiara Milano, Laura Marmolejo, et al.
Brain : a Journal of Neurology|July 12, 2025
Brain atrophy patterns in anti-IgLON5 diseaseSelina M Yogeshwar, Frederik Bartels, Thomas Grüter, et al.
Brain : a Journal of Neurology|March 1, 2024
HLA-DQB1*05 subtypes and not DRB1*10:01 mediates risk in anti-IgLON5 diseaseSelina M Yogeshwar, Sergio Muñiz-Castrillo, Lidia Sabater, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 13, 2026
Muscle Regeneration Failure May Lead to Clinical Features of Myopathy in Anti-IgLON5 DiseaseYvette S Crijnen, Verena Endmayr, Suzanne C Franken, et al.
Acta Neuropathologica|October 14, 2024
Neuropathological spectrum of anti-IgLON5 disease and stages of brainstem tau pathology: updated neuropathological research criteria of the disease-related tauopathyEllen Gelpi, Raphael Reinecke, Carles Gaig, et al.
Pageof 10